DIVIS LABORATORIES
Back to Balance Sheet
|
DIVIS LABORATORIES Last 5 Year Capital Work in Progress History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Capital Work in Progress | ₹1,022 Cr | ₹778 Cr | ₹212 Cr | ₹470 Cr | ₹711 Cr |
What is the latest Capital Work in Progress ratio of DIVIS LABORATORIES ?
| Year | Capital Work in Progress |
|---|---|
| Mar2025 | ₹1,022 Cr |
| Mar2024 | ₹778 Cr |
| Mar2023 | ₹212 Cr |
| Mar2022 | ₹470 Cr |
| Mar2021 | ₹711 Cr |
How is Capital Work in Progress of DIVIS LABORATORIES Trending?
| Years | Capital Work in Progress | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,022 Cr | 31.36 | |
| Mar2024 | ₹778 Cr | 266.98 | |
| Mar2023 | ₹212 Cr | -54.89 | |
| Mar2022 | ₹470 Cr | -33.87 | |
| Mar2021 | ₹711 Cr | - | |
Compare Capital Work in Progress of peers of DIVIS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DIVIS LABORATORIES | ₹178,239.4 Cr | 1.1% | -0.7% | -1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹432,036.0 Cr | 0.8% | -4.2% | 7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹151,099.0 Cr | 0% | 1.3% | 40.1% | Stock Analytics | |
| CIPLA | ₹110,897.0 Cr | -0.3% | -4.1% | -8.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,591.0 Cr | 0.4% | -4.5% | -5.2% | Stock Analytics | |
| MANKIND PHARMA | ₹97,332.8 Cr | -0.6% | -5.9% | 0.1% | Stock Analytics | |
DIVIS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DIVIS LABORATORIES | 1.1% |
-0.7% |
-1% |
| SENSEX | 3.9% |
1.9% |
-6.8% |
You may also like the below Video Courses